WMJ Vol 121 Issue 3: Patients’ View of Their Primary Care Telemedicine During the COVID-19 Pandemic and Implications for Future Integration: A Multimethod Study

ABSTRACT

Introduction: Telemedicine has become an integral part of primary care since the COVID-19 pandemic. This paper reports patients’ assessments of their early telemedicine visits.

Methods: Adult primary care patients who had a telemedicine visit were identified from electronic medical records of a large Midwestern health system and randomly invited to participate in semistructured interviews. Participants compared telemedicine visits (audio and video) to face-to-face visits on measures of satisfaction and answered open-ended questions about the technology, primary care relationships, and ongoing use of telemedicine. Interviews were recorded and responses transcribed for qualitative analysis.

Results: The quantitative results revealed participants valued convenience and judged telemedicine visits “about the same” as office visits on satisfaction measures. Participants were largely willing to have another telemedicine visit but were concerned with the technological challenges and lack of physical examination. The qualitative analysis found most participants reported that telemedicine care was best with a known clinician. Further, they judged telemedicine to be best for follow-ups and simple or single problems and believed it should be balanced with face-to-face visits.

Conclusions: Participants expect telemedicine will continue and have clearly articulated their telemedicine preferences. These preferences include telemedicine with a known clinician, the visits that they judged most appropriate for telemedicine, the need to balance telemedicine with face-to-face visits, and assured technologic access. The need for quality measures beyond patient satisfaction and the role of team-based telemedicine care emerged as areas for further research.

Intended Audience

The target audience for this journal-based activity is healthcare providers caring for the people and communities of Wisconsin and beyond.

Learning Objectives

As a result of this journal-based activity, learners will be able to:

  1. Summarize the results of a study exploring primary care telemedicine during the COVID-19 pandemic that pertain to patient satisfaction and comparison of telemedicine visits to face-to-face visits.
  2. Interpret the study results pertaining to telemedicine preferences and challenges expressed during patient interviews.
  3. Discuss implications of this study for the learner practice and team-based telemedicine care.
    Course summary
    Available credit: 
    • 1.00 AAPA Category 1 CME
    • 1.00 AMA PRA Category 1 Credit
    • 1.00 ANCC Contact Hours
    • 1.00 University of Wisconsin–Madison Continuing Education Hours
      • 1.00 Approved for AMA PRA Category 1 Credit™
    Registration opens: 
    05/04/2023
    Course expires: 
    05/03/2024
    Cost:
    $0.00
    Rating: 
    0

    FACULTY DISCLOSURE

    It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

    For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

    Name of IndividualIndividual's Role in Activity

    Financial Relationship Disclosure

    Discussion of
    Unlabeled/Unapproved
    Uses of Drugs/Devices
    in Presentation?

    Shezad BalochAccreditation SpecialistNo relevant relationships with ineligible companies to discloseNo
    Ellen Goldstein, MDAuthorNo relevant relationships with ineligible companies to discloseNo
    Kendra Nervik, Phd(c)AuthorNo relevant relationships with ineligible companies to discloseNo
    Collin Ellenbecker, BSCAuthorNo relevant relationships with ineligible companies to discloseNo
    Wen-Jan Tuan, DHA, MS, MPHAuthorNo relevant relationships with ineligible companies to discloseNo
    Mark A. Micek, MD, MPHAuthorNo relevant relationships with ineligible companies to discloseNo
    Ellen Goldstein, PhD, MFTAuthorNo relevant relationships with ineligible companies to discloseNo
    John J. Frey, MDReviewerNo relevant relationships with ineligible companies to discloseNo
    Sabina Diehr, MDReviewerNo relevant relationships with ineligible companies to discloseNo
    Elizabeth Bade, MDReviewerNo relevant relationships with ineligible companies to discloseNo
    David Dwyer, Phd., RN, NE-BCReviewer No relevant relationships with ineligible companies to discloseNo
    Laura Ozkan, PAReviewer No relevant relationships with ineligible companies to discloseNo
    Fahad Aziz, MDEditorNo relevant relationships with ineligible companies to discloseNo

    *Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

    The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.

    Discloser List CME Internal Report

    Accreditation

    Accreditation Statement

    Jointly Accredited Provider LogoIn support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal.  The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Credit Designation Statements

    American Medical Association (AMA)

    The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Continuing Education Units

    The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.

    Available Credit

    • 1.00 AAPA Category 1 CME
    • 1.00 AMA PRA Category 1 Credit
    • 1.00 ANCC Contact Hours
    • 1.00 University of Wisconsin–Madison Continuing Education Hours
      • 1.00 Approved for AMA PRA Category 1 Credit™

    Cost:
    $0.00
    Please login or register to take this course.

    Required Hardware/software

    Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly. 

    Free, current version of Adobe Acrobat Reader or other .pdf reader.